DUSA Pharmaceuticals

DUSA Pharmaceuticals, Inc.
Public
Industry Pharmaceuticals,
Healthcare
Headquarters Wilmington, Massachusetts, USA
Key people
 D. Geoffrey Shulman, MD, FRCP, Founder, Chairman, and CSO
Robert F. Doman, President and CEO
Products Levulan Kerastick,
BLU-U,
ClindaReach,
Psoriatec,
METED Shampoo,
Nicomide
Website http://www.dusapharma.com/

DUSA Pharmaceuticals, Inc. (NASDAQ: DUSA) is pharmaceutical company based in Wilmington, Massachusetts that specializes in dermatology products. The major focus of the company includes medications used in the treatment of actinic keratoses and acne.

In the first quarter of 2006, DUSA Pharmaceuticals obtained Sirius Laboratories Inc. in a merger estimated to be worth 30 million dollars. Sirius was a privately held dermatology specialty pharmaceuticals company founded by Dr. Joel E. Bernstein in 2000 dedicated to the treatment of acne vulgaris and acne rosacea.[1]

External links

References

  1. ↑ "DUSA Pharmaceuticals Closes Acquisition of Sirius Laboratories". BNET. 2006-04-14. Retrieved 2008-08-26.